AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug

AstraZeneca and Daiichi Sankyo have secured FDA breakthrough therapy status for gastric cancer drug Enhertu. (Credit: AstraZeneca)